Massachusetts Selecta Biosciences' CEO to Retire at the End of 2018 Post author:Sam Post published:January 1, 2018 Post category:BioPharma Werner Cautreels, Ph.D., intends to retire effective December 31, 2018. Source: BioSpace You Might Also Like Cambridge's Proteostasis Slashes R&D Jobs in Focus Shift November 1, 2017 Tiny New York Biotech With Ties To Massachusetts, Syntimmune, Gets A $50 Million Boost June 20, 2017 Booming Regeneron to Hire 300 New Workers in Ireland October 26, 2017
